Abstract:
:Targeted ultrasound contrast imaging has the potential to become a reliable molecular imaging tool. A better understanding of the quantitative aspects of molecular ultrasound technology could facilitate the translation of this technique to the clinic for the purposes of assessing vascular pathology and detecting individual response to treatment. The objective of this study was to evaluate whether targeted ultrasound contrast-enhanced imaging can provide a quantitative measure of endogenous biomarkers. Endoglin, an endothelial biomarker involved in the processes of development, vascular homeostasis, and altered in diseases, including hereditary hemorrhagic telangiectasia type 1 and tumor angiogenesis, was the selected target. We used a parallel plate perfusion chamber in which endoglin-targeted (MBE), rat isotype IgG2 control and untargeted microbubbles were perfused across endoglin wild-type (Eng+/+), heterozygous (Eng+/-) and null (Eng-/-) embryonic mouse endothelial cells and their adhesion quantified. Microbubble binding was also assessed in late-gestation, isolated living transgenic Eng+/- and Eng+/+ embryos. Nonlinear contrast-specific ultrasound imaging performed at 21 MHz was used to collect contrast mean power ratios for all bubble types. Statistically significant differences in microbubble binding were found across genotypes for both in vitro (p<0.05) and embryonic studies (p<0.001); MBE binding was approximately twofold higher in Eng+/+ cells and embryos compared with their Eng+/- counterparts. These results suggest that molecular ultrasound is capable of reliably differentiating between molecular genotypes and relating receptor densities to quantifiable molecular ultrasound levels.
journal_name
Angiogenesisjournal_title
Angiogenesisauthors
Denbeigh JM,Nixon BA,Lee JJ,Jerkic M,Marsden PA,Letarte M,Puri MC,Foster FSdoi
10.1007/s10456-014-9447-0subject
Has Abstractpub_date
2015-01-01 00:00:00pages
69-81issue
1eissn
0969-6970issn
1573-7209journal_volume
18pub_type
杂志文章相关文献
ANGIOGENESIS文献大全abstract::Among the key effects of fluid shear stress on vascular endothelial cells is modulation of gene expression. Promoter sequences termed shear stress response elements (SSREs) mediate the responsiveness of endothelial genes to shear stress. While previous studies showed that shear stress responsiveness is mediated by a s...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-009-9143-7
更新日期:2009-01-01 00:00:00
abstract::De novo synthesis of cytoskeleton-regulatory proteins triggered by the megakaryoblastic leukemia (MKL)/serum response factor (SRF) transcriptional system in response to pro-angiogenic growth factors lies at the heart of endothelial cell (EC) migration (a critical element of angiogenesis) and neovascularization. This s...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-017-9560-y
更新日期:2017-11-01 00:00:00
abstract::Evidence has been gathered regarding the association between angiogenesis and inflammation in pathological situations. These two phenomena have long been coupled together in many chronic inflammatory disorders with distinct etiopathogenic origin, including psoriasis, rheumatoid arthritis, Crohn's disease, diabetes, an...
journal_title:Angiogenesis
pub_type: 杂志文章,评审
doi:10.1007/s10456-007-9074-0
更新日期:2007-01-01 00:00:00
abstract::Ocular angiogenesis is responsible for the majority of irreversible blindness in the developed world [1]. This debilitating complication affects all age groups and characterizes such diverse and widespread diseases as trachoma, retinopathy of prematurity, diabetic retinopathy, neovascular glaucoma and age-related macu...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1023/a:1009071601454
更新日期:1999-01-01 00:00:00
abstract:PURPOSE:There are currently no validated biomarkers predicting bevacizumab treatment outcome or toxicity. We combined biomarker data from six phase III trials of bevacizumab to assess whether genetic variation in vascular endothelial growth factor-A (VEGF-A) pathway or hypertension-related genes are associated with bev...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-014-9424-7
更新日期:2014-07-01 00:00:00
abstract::Corneal vascularisation is a potentially devastating occurrence that can cause blindness. Currently, treatments for this condition are limited. In these studies, we have investigated a novel inhibitor of angiogenesis, 12-methyl tetradecanoic acid (12-MTA), to treat corneal vascularisation in mouse models of corneal al...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-007-9063-3
更新日期:2007-01-01 00:00:00
abstract::Sunitinib is a potent and clinically approved tyrosine kinase inhibitor that can suppress tumour growth by inhibiting angiogenesis. However, conflicting data exist regarding the effects of this drug on the growth of metastases in preclinical models. Here we use 4T1 and RENCA tumour cells, which both form lung metastas...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-012-9291-z
更新日期:2012-12-01 00:00:00
abstract::Kaposi's sarcoma (KS) is a vascular neoplasm caused by infection of endothelial or endothelial precursor cells with the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8). Research efforts have focused on defining the molecular events explaining how KSHV promotes pathological angiogenesis and KS tumor formation. mTOR...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-015-9475-4
更新日期:2015-10-01 00:00:00
abstract::Both vasculogenesis and angiogenesis occur during normal placental vascular development. Additionally, the placenta undergoes a process of vascular mimicry (pseudo-vasculogenesis) where the placental extravillous trophoblast (EVT) that invade the spiral arteries convert from an epithelial to an endothelial phenotype d...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-012-9317-6
更新日期:2013-04-01 00:00:00
abstract:OBJECTIVE:Dysregulation of the phosphatidylinositol-3-kinase (PI3K) signaling pathway is a hallmark of human cancer, occurring in a majority of tumors. Activation of this pathway is critical for transformation and also for the angiogenic switch, which is a key step for tumor progression. The objective of this study was...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-009-9154-4
更新日期:2009-01-01 00:00:00
abstract::Anti-angiogenesis is likely to develop into a novel therapeutic approach for patients with solid malignancies. Most current clinical trials evaluate anti-angiogenic drugs aimed primarily against single angiogenesis stimulators. Here, we show that a single solid malignancy, i.e., a human embryonal rhabdomyosarcoma, pro...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1023/a:1016045012466
更新日期:2001-01-01 00:00:00
abstract::Angiogenesis, a crucial step in tumor growth and metastasis, is regulated by various pro- or anti-angiogenic factors. Recently, microRNAs have been shown to modulate angiogenic processes by modulating the expression of critical angiogenic factors. However, roles of tumor-derived microRNAs in regulating tumor vasculari...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-015-9474-5
更新日期:2015-07-01 00:00:00
abstract::Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel development upon activation of three receptor tyrosine kinases (VEGFRs). The extracellular domain of VEGFRs consists of seven Ig-homology domains, of which D2-3 form the ligand-binding site, while the membrane proximal domains D4-7 are involve...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-018-9606-9
更新日期:2018-08-01 00:00:00
abstract::Cancer cells have diverse mechanisms for utilizing the vasculature; they can initiate the formation of new blood vessels from preexisting ones (sprouting angiogenesis) or they can form cohesive interactions with the abluminal surface of preexisting vasculature in the absence of sprouting (co-option). The later process...
journal_title:Angiogenesis
pub_type: 杂志文章,评审
doi:10.1007/s10456-019-09684-y
更新日期:2020-02-01 00:00:00
abstract::In this study we investigated the control of the angiogenic/haemorrhagic phenotype of oestrogen-induced rat pituitary tumours of an F1 hybrid (F1) of Fischer 344 (F344) (tumour susceptible) and Brown Norway (tumour resistant) strains. F1 forms a pituitary tumour upon chronic oestrogen treatment, but microvessel count ...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1023/a:1021550211921
更新日期:2002-01-01 00:00:00
abstract::Endothelial cells are known to be a rich source of transcriptional gene expression. Recent technological advances now permit the detailed profiling of mRNA expression using arrays of known cDNAs on blots. We have used such arrays to examine expression of mRNA by primary isolates of human foreskin microvascular endothe...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1023/a:1009085422384
更新日期:1999-01-01 00:00:00
abstract::During the early stages of angiogenesis, following stimulation of endothelial cells by vascular endothelial growth factor (VEGF), the vascular wall is breached, allowing high molecular weight proteins to leak from the vessels to the interstitial space. This hallmark of angiogenesis results in deposition of a provision...
journal_title:Angiogenesis
pub_type: 杂志文章,评审
doi:10.1007/s10456-010-9170-4
更新日期:2010-06-01 00:00:00
abstract::Although monotherapy with angiostatic drugs is still far from effective, there is abundant evidence that angiostatic therapy can improve the efficacy of conventional treatments like radiotherapy. This has instigated numerous efforts to optimize and clinically implement the combination of angiostatic drugs with radiati...
journal_title:Angiogenesis
pub_type: 历史文章,杂志文章,评审
doi:10.1007/s10456-017-9546-9
更新日期:2017-05-01 00:00:00
abstract::Chemokine (C-C motif) receptor-2 (CCR2) regulates arteriogenesis and angiogenesis, facilitating the MCP-1-dependent recruitment of growth factor-secreting bone marrow-derived cells (BMCs). Here, we tested the hypothesis that the BMC-specific expression of CCR2 is also required for new arteriole formation via capillary...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-009-9157-1
更新日期:2009-01-01 00:00:00
abstract::Vascular endothelial growth factor receptor 2 (VEGFR-2) and α v ß 3 integrin are the most frequently addressed targets in molecular imaging of tumor angiogenesis. In preclinical studies, molecular imaging of angiogenesis has shown potential to detect and differentiate benign and malignant lesions of the breast. Thus, ...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-016-9499-4
更新日期:2016-04-01 00:00:00
abstract::Heparan sulfate (HS), a long linear polysaccharide of alternating disaccharide residues, interacts with a wide variety of proteins, including many angiogenic factors. The involvement of HS in signaling of pro-angiogenic factors (e.g. vascular endothelial growth factor and fibroblast growth factor 2), as well as intera...
journal_title:Angiogenesis
pub_type: 杂志文章,评审
doi:10.1007/s10456-013-9401-6
更新日期:2014-07-01 00:00:00
abstract::Vascular anomalies can cause significant morbidity and mortality. Advances in diagnosis will be improved if noninvasive biomarkers can be identified, as obtaining a tissue biopsy can worsen the disease and precipitate complications. The goal of this study was to identify biomarkers for vascular anomaly patients to aid...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-016-9537-2
更新日期:2017-02-01 00:00:00
abstract::The hst-1 gene product, one of the fibroblast growth factor family proteins, has transforming and angiogenic activities. The BALB/c 3T3 cell line was transfected with an expression vector harboring human hst-1 cDNA and the malignant properties of two stably transfected clones, TC-1 and TC-2, were examined. The stimula...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1023/a:1009288405970
更新日期:1998-01-01 00:00:00
abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) that is secreted by tumor cells plays a key role in angiogenesis. Matrix metalloproteinase 9 (MMP-9) is produced by inflammatory cells, such as stromal granulocytes (PMN), remodels the extracellular matrix and is known to promote angiogenesis indirectly by interactin...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-011-9207-3
更新日期:2011-09-01 00:00:00
abstract:BACKGROUND:Vasculogenic mimicry (VM) is the formation of vascular channels by tumor cells or tumor cell-derived, trans-differentiated cells in highly aggressive, solid tumors. However, the disease features and prognostic value of VM for overall survival of cancer patients remain controversial. METHOD:To systematically...
journal_title:Angiogenesis
pub_type: 杂志文章,meta分析
doi:10.1007/s10456-016-9500-2
更新日期:2016-04-01 00:00:00
abstract::Angiogenesis was postulated to be a critical prognostic factor and therapeutic focus for malignancy more than two decades ago. Recent studies indicate quantitative assessments of microvessel count to be an independent prognostic variable for disease-free and overall survival in a wide variety of tumors, and that angio...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1023/A:1018301031580
更新日期:1997-01-01 00:00:00
abstract:INTRODUCTION:Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with s...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-019-09704-x
更新日期:2020-05-01 00:00:00
abstract::The sprouting of endothelial cells from pre-existing blood vessels represents a critical event in the angiogenesis cascade. However, only a fraction of cultured or transplanted endothelial cells form new vessels. Moreover, it is unclear whether this results from a stochastic process or instead relates to certain endot...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-014-9414-9
更新日期:2014-07-01 00:00:00
abstract:INTRODUCTION:Clinical and pathological characteristics are still considered prognostic markers in metastatic non-small-cell lung cancer (NSCLC) patients but they cannot explain all interindividual variability. Tumoral angiogenesis mediated by the vascular endothelial growth factor (VEGF) is critical for the progression...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-019-09668-y
更新日期:2019-08-01 00:00:00
abstract::Therapeutic over-expression of vascular endothelial growth factor (VEGF) can be used to treat ischemic conditions. However, VEGF can induce either normal or aberrant angiogenesis depending on its dose in the microenvironment around each producing cell in vivo, which limits its clinical usefulness. The goal herein was ...
journal_title:Angiogenesis
pub_type: 杂志文章
doi:10.1007/s10456-012-9304-y
更新日期:2013-01-01 00:00:00